ANESIVA, INC.

Anesiva is based out of South San Francisco. Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management. It has two products in clinical development, which include Zingo and 4975. Zingo is an anesthetic that has completed two Phase 3 trials in the pediatric population for the treatment of pain associated with venipuncture and cannulation; and 4975 is an anesthetic for the treatment of site-specific moderate to severe pain, and is in multiple Phase 2 and Phase 3 trials in post-surgical and musculoskeletal pain.Whalewisdom has at least 51 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2009-10-02. The notice included securities offered of Debt